CTI BioPharma (CTIC) Competitor Comparison
We are evaluating the key criteria listed to compare CTI BioPharma (CTIC) against its competitors in the Biotechnology industry.
Market Capitalization
117 / 368Gross Profits
64 / 278Total Revenue
104 / 300EBITDA
143 / 337Free Cashflow
272 / 352Quick Ratio
322 / 357Earnings per Share
84 / 359Dividend yield
0 / 6Total Cash
251 / 358Performance 3 years
10 / 368Performance 5 years
87 / 368Performance 10 years
117 / 368Linearity 3 years
365 / 368Linearity 5 years
341 / 368Linearity 10 years
20 / 368Total Rank
97 / 368Dividend Rank
98 / 368Valuation Rank
199 / 368Piotroski Rank
20 / 368Muliplier Rank
321 / 368Muliplier Rank - CTIC ranking 321 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.